WAY Stock Analysis: Buy, Sell, or Hold?
WAY - Waystar Holding Corp. Common Stock
$23.46
2.03 (9.47%)
▲
5d:
+23.73%
30d:
+12.68%
90d:
-1.3%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 29, 2026
24d
Smart Money Distribution
None View Scanner →
Strength: 4.6/10
Get Alerted When WAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: WAY is 12.8% above its trading range ($20.80). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: WAY is 12.8% above its trading range ($20.80). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.45
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$24.50
4.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WAY is currently trading at $23.46, which is considered extended relative to its 30-day fair value range of $18.26 to $20.80. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.7) compared to its historical average (14.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This pessimistic expectation contrasts with the company's recent 37.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is approaching resistance at $23.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.68 (+43.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WAY is in a strong downtrend. The price is approaching resistance at $23.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 9.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.68 (+43.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.26 -
$20.80
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
Protect Your Profits
Holding WAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.8% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.5%)
- BULLISH: Trading 43.6% below Wall St target ($33.68)
Trading Range Analysis
30-Day Trading Range
$18.26 -
$20.80
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.26
Resistance Level
$23.70
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.70
Wall Street Target
$33.68
(+43.6%)
Revenue Growth (YoY)
22.4%
Earnings Growth (YoY)
37.5%
Profit Margin
10.9%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
12.7 vs 14.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$22.50
(-4%)
2-Year Target
$21.58
(-8%)
3-Year Target
$20.69
(-12%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$23.46
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.5%)
$57.32
(+144%)
Base:
(SPY PE: 12.7, Growth: 12.5%)
$33.43
(+43%)
Bear:
(PE: 10.8, Growth: 12.5%)
$28.42
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 31.99 | Current EPS (TTM): $0.67
Bull Case
$47.15
(+101%)
Analyst growth 100.0%, PE expands to 35.2
Base Case
$42.86
(+83%)
Market implied 100.0%, PE stable at 32.0
Bear Case
$14.57
(-38%)
Severe decline -20.0%, PE contracts to 27.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.7 to 14.4
Stabilization Target:
$26.59
(+13.4%)
PE Expansion Potential:
+13.4%
Share & Embed Analysis
Last updated: July 03, 2026 8:32 PM ET
Data refreshes hourly during market hours. Next update: 9:32 PM
Data refreshes hourly during market hours. Next update: 9:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric L (Ric) Sinclair III
SELL
40225 shares
2026-01-20
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
Advanced WAY Option Strategies
Professional options setups generated by AI based on today's WAY price and gamma walls.
